Editors:
Offers a valuable reference work on cancer therapies for all levels of expertise
Structures information on cancer therapeutic targets, with regular updates
Provides expert editors’ overviews for each target
Covers relevant biology, potential as cancer targets, agents tested and available clinical data
Includes supplementary material: sn.pub/extras
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (95 entries)
-
Front Matter
About this book
In the past decade, we have experienced an explosion of new information about cancer therapeutic targets. Many of the targets have been validated by the discovery and approval of new medicines which have been approved for the treatment of cancer. On the heels of these successes, innumerable new targets and new potential therapeutics are being developed by many different groups including government agencies, pharmaceutical companies, biotechnology companies, academic institutions, and individual investigators. Understanding the expanding "universe" of cancer therapies is therefore becoming impossible and no single source exists which serves as a reference for the involved parties. Further, the interested parties have vastly different areas of expertise, from focused laboratory based science, to clinical research, to corporate and regulatory oversight.
The text would be updated every two years, more often depending on pace of change, interest and sales. While useful online, this reference book would likely be kept in hard copy as well.
Editors and Affiliations
-
Division of Hematology & Oncology, Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA
John L. Marshall
About the editor
Editorial Board:
- John L. Marshall (Editor in Chief), Department of Hematology and Oncology, Otto J Ruesch Center for the Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC, USA
- Howard L. Kaufman, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA
- Lee M. Ellis, Department of Surgical Oncology and Molecular & Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Louis M. Weiner, Georgetown Lombardi Comprehensive Cancer Center, Georgetown University School of Medicine, Washington DC, USA
- Emanuel F Petricoin, Center for Applied Proteomics and Molecular Medicine, School of Systems Biology, George Mason University, Institute of Advanced Biomedical Research, Manassas, VA, USA
- Edward P. Gelmann, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, USA
Bibliographic Information
Book Title: Cancer Therapeutic Targets
Editors: John L. Marshall
DOI: https://doi.org/10.1007/978-1-4419-0717-2
Publisher: Springer New York, NY
eBook Packages: Biomedical and Life Sciences, Reference Module Biomedical and Life Sciences
Copyright Information: Springer Science+Business Media New York 2017
Hardcover ISBN: 978-1-4419-0716-5Published: 09 April 2017
eBook ISBN: 978-1-4419-0717-2Published: 07 April 2017
Edition Number: 1
Number of Pages: XXXII, 1105
Number of Illustrations: 9 b/w illustrations, 42 illustrations in colour
Topics: Cancer Research, Oncology, Laboratory Medicine, Internal Medicine, Molecular Medicine, Pharmacology/Toxicology